Pivotal Response Treatment for School-Aged Children and Adolescents with Autism Spectrum Disorder: A Randomized Controlled Trial

Pivotal Response Treatment (PRT) is promising for children with Autism Spectrum Disorder (ASD), but more methodologically robust designed studies are needed. In this randomized controlled trial, forty-four children with ASD, aged 9–15 years, were randomly allocated to PRT ( n  = 22) or treatment-as-...

Full description

Saved in:
Bibliographic Details
Published inJournal of autism and developmental disorders Vol. 51; no. 12; pp. 4506 - 4519
Main Authors de Korte, Manon W. P., van den Berk-Smeekens, Iris, Buitelaar, Jan. K., Staal, Wouter G., van Dongen-Boomsma, Martine
Format Journal Article
LanguageEnglish
Published New York Springer US 01.12.2021
Springer
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Pivotal Response Treatment (PRT) is promising for children with Autism Spectrum Disorder (ASD), but more methodologically robust designed studies are needed. In this randomized controlled trial, forty-four children with ASD, aged 9–15 years, were randomly allocated to PRT ( n  = 22) or treatment-as-usual (TAU; n  = 22). Measurements were obtained after 12- and 20-weeks treatment, and 2-month follow-up. PRT resulted in significant greater improvements on parent-rated social-communicative skills after 12 weeks treatment ( p  = .004, partial η 2  = 0.22), compared to TAU. Furthermore, larger gains in PRT compared to TAU were observed on blindly rated global functioning, and parent-rated adaptive socialization skills and attention problems. Implications for clinical practice and suggestions for future research are discussed.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
ISSN:0162-3257
1573-3432
DOI:10.1007/s10803-021-04886-0